"m o s" Pill Images
The following drug pill images match your search criteria.

1 / 4
Loading
WPI 22 26

NVR D25
Dexmethylphenidate Hydrochloride Extended-Release
- Strength
- 25 mg
- Imprint
- NVR D25
- Color
- Blue & White
- Shape
- Capsule/Oblong

625 30 mg
Dexmethylphenidate Hydrochloride Extended-Release
- Strength
- 30 mg
- Imprint
- 625 30 mg
- Color
- Yellow & White
- Shape
- Capsule/Oblong
Featured

Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Reviews & ratings
1 / 2
Loading
cor 216

MYLAN DA 15 MYLAN DA 15
Dextroamphetamine Sulfate Extended-Release
- Strength
- 15 mg
- Imprint
- MYLAN DA 15 MYLAN DA 15
- Color
- Brown & White
- Shape
- Capsule/Oblong

D 50 M
Diclofenac Sodium and Misoprostol Delayed-Release
- Strength
- 50 mg / 200 mcg
- Imprint
- D 50 M
- Color
- White
- Shape
- Round

1 / 3
Loading
93 3125 93 3125
Dicloxacillin Sodium
- Strength
- 500 mg
- Imprint
- 93 3125 93 3125
- Color
- Green
- Shape
- Capsule/Oblong

RG83 RG83
Diltiazem Hydrochloride Extended-Release
- Strength
- 120 mg
- Imprint
- RG83 RG83
- Color
- Blue
- Shape
- Capsule/Oblong

SS2
Docusate Sodium and Senna
- Strength
- docusate sodium 50 mg / sennosides 8.6 mg
- Imprint
- SS2
- Color
- Red
- Shape
- Round

1 / 2
Loading
AN 1247
Donepezil Hydrochloride and Memantine Hydrochloride Extended-Release
- Strength
- 10 mg / 28 mg
- Imprint
- AN 1247
- Color
- Yellow
- Shape
- Capsule/Oblong

RB66 20 mg
Esomeprazole Magnesium Delayed Release
- Strength
- 20 mg
- Imprint
- RB66 20 mg
- Color
- Pink
- Shape
- Capsule/Oblong

RB67 40 mg
Esomeprazole Magnesium Delayed Release
- Strength
- 40 mg
- Imprint
- RB67 40 mg
- Color
- Pink
- Shape
- Capsule/Oblong

G 59
Esomeprazole Magnesium Delayed Release
- Strength
- 20 mg
- Imprint
- G 59
- Color
- Blue
- Shape
- Capsule/Oblong

L 94 20 mg
Esomeprazole Magnesium Delayed-Release
- Strength
- 20 mg
- Imprint
- L 94 20 mg
- Color
- Purple
- Shape
- Capsule/Oblong
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.